about
Mechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionRunx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition.Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation.High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patientsSite-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancerClinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer.Recent advances in understanding contextual TGFβ signalingHook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinoma.SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC.Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.Orchestration of the crosstalk between astrocytes and cancer cells affects the treatment and prognosis of lung cancer sufferers with brain metastasis.Molecular insights into tumour metastasis: tracing the dominant events.YAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor.Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.Dichotomous roles of TGF-β in human cancer.TGF-β Family Signaling in the Control of Cell Proliferation and Survival.TGF-β Family Signaling in Tumor Suppression and Cancer Progression.SP and KLF Transcription Factors in Digestive Physiology and Diseases.Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis (Review)Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition.TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway.Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis.TGF-β in pancreatic cancer initiation and progression: two sides of the same coinTGF-β Conveys Undesirable Side Effects of Androgen Depletion.Autophagy acts through TRAF3 and RELB to regulate gene expression via antagonism of SMAD proteins.Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma.SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.The fibrotic tumor stroma.Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion.YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.
P2860
Q26745545-2CF3E4B2-B4A6-44C0-A231-5EF7AD8A76E1Q33566597-5E8283CB-5922-4937-A886-14055204005BQ33577449-0E09C90A-BD9C-497D-8D53-F35890E4B2F6Q33798379-6C1144F2-1039-4C42-ABBE-63688E45EA75Q36296731-38B3620F-9DCE-411F-8921-206BD1E3ABC1Q36306603-DDF54CFE-6E64-4B88-8D45-D500D0BE7E9BQ37587988-F029694D-8B39-46DF-89C5-0282A4A08F53Q37706944-DEBB5C71-4DCF-49EC-8218-1C6A0278DB88Q37725506-05A35B3F-6BD1-40E2-A963-33855FFD273DQ38601572-CF9E2D06-D2FC-4FD0-AD5B-8862BBC40566Q38666840-93FB367D-F746-45AF-A276-8F731290B740Q38697003-2140D3EA-C9CC-4B0B-80DD-55EEFE0F165DQ38702971-997E0E1C-277A-46DA-B25C-104375E74647Q38711211-D9A6C152-F07F-4F9D-BE69-22BF3E1C7B5AQ38712381-2A95804A-F7CB-4C19-BCA9-40EF6104B0CAQ38716717-A4EE0703-9F8A-460C-8C26-2692396D8B2AQ38724705-5BF30ECF-A6DD-417C-BEDF-83E027E4C993Q38773136-BCC1DF2B-452F-4F18-B362-20305DD2BFE7Q38776336-3C50CA18-8C27-465E-9E6D-1786A28C1757Q38829202-DEB5B517-2480-4D22-B434-433746334666Q38850621-4A50A3BA-4AE6-4024-A3B1-58F2CAB253AAQ38998166-E93ED067-C3B7-406A-A609-5AA8073E04FBQ39027205-CCD8113D-4C40-43A6-BBED-4AB80A3206D5Q39029986-6C2A29EF-C930-46C3-B673-75520E94B399Q39155158-1CE4E749-4EBB-478F-931D-8B733C753EC4Q39214035-29F30673-FD07-4684-BD42-1C383F2DC11BQ39382387-DCABF788-F74A-4511-BA12-C14B502D6C2BQ39540701-E22CC6F5-47E5-4600-A6B2-DF5F7A0060DDQ39739202-EC6EEBF8-46A9-4090-8BD2-488A068F06BCQ40042902-5B85D2FC-71EE-48AC-BF96-160787AFF11AQ41105264-8F61339F-183F-4681-80E5-64E9160E0600Q41272730-A9B542E4-AF2D-4040-8237-58FD6E80A41CQ42724556-A0D8C693-E001-4C2A-B063-5219F7D11193Q46675174-FB5845EA-A717-4AD2-85C9-80C43E1BB2FCQ47112052-D1AF9CE9-AC43-4750-821F-BD726AF997CCQ47114737-7775A6E9-FAA5-49FE-B1F0-FEEE480EC722Q47205727-AA581071-D2F7-463C-AB5A-A68CB5E3B3D2Q47329309-4796FE3E-7C91-4B5C-96A4-D7F21087F8A0Q47351806-439B3BD7-4E53-47C6-B0ED-14E05F602820Q47405466-5DAD5E8C-FE4C-4CCF-BB68-51890CBB1979
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
TGF-β Tumor Suppression through a Lethal EMT.
@en
TGF-β Tumor Suppression through a Lethal EMT.
@nl
type
label
TGF-β Tumor Suppression through a Lethal EMT.
@en
TGF-β Tumor Suppression through a Lethal EMT.
@nl
prefLabel
TGF-β Tumor Suppression through a Lethal EMT.
@en
TGF-β Tumor Suppression through a Lethal EMT.
@nl
P2093
P2860
P50
P1433
P1476
TGF-β Tumor Suppression through a Lethal EMT.
@en
P2093
Charles J David
Christine A Iacobuzio-Donahue
Nabeel Bardeesy
P2860
P304
P356
10.1016/J.CELL.2016.01.009
P407
P577
2016-02-17T00:00:00Z